Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash Flows From Operating Activities:
Net income	$ 4,979	$ 5,138
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion	1,622	1,806
Provision for credit losses	730	1,105
Stock based compensation	940	342
Net gain on sale of securities	(431)	(78)
Net loss on sale and write down of OREO and other repossessed property	644	134
Earnings from investment in BOLI	(226)	(228)
Deferred tax expense (benefit)	344	(88)
Proceeds from sales of loans	12,246	18,739
Loans originated for sale	(12,207)	(17,638)
Gain on sale of loans	(39)	(484)
Gain on insurance proceeds	(1,180)	(120)
Write off of property and equipment		698
Increase in accrued interest receivable	(59)	(157)
Decrease (increase) in other assets	4,859	(475)
Increase (decrease) in accrued interest payable	60	(6)
Decrease in other liabilities	(1,772)	(260)
Net Cash Provided By Operating Activities	10,510	8,428
Cash Flows From Investing Activities:
Activity in available-for-sale securities: Sales	43,913	17,988
Activity in available-for-sale securities: Maturities, repayments and calls	55,195	58,262
Activity in available-for-sale securities: Purchases	(59,646)	(57,928)
Activity in held-to-maturity securities: Sales	761
Activity in held-to-maturity securities: Maturities, repayments and calls	13,647	1,822
Activity in held-to-maturity securities: Purchases	(13,507)	(10,093)
Net cash disbursed in connection with acquisition	(5,488)
Net decrease (increase) in restricted stock	999	(860)
Net increase in loans	(29,693)	(29,020)
Proceeds from insurance company	1,180	1,250
Purchases of office property and equipment	(3,181)	(1,791)
Expenses capitalized in OREO	(1,236)	(202)
Proceeds from sale of OREO and other repossessed property	432	177
Net Cash Provided By (Used In) Investing Activities	3,376	(20,395)
Cash Flows From Financing Activities:
Net increase in deposits	51,759	1,192
Repayment of FHLBP advances	(43,104)	(10,000)
Funding of FHLBP advances		20,000
Net (decrease) increase in repurchase agreements	(20,527)	13,195
Proceeds from issuance of subordinated debt		9,750
Decrease in other borrowings	(46)	(41)
Dividends paid	(895)	(834)
Proceeds from the exercise of stock options		402
Taxes on stock option exercise and share award vest	(701)	(469)
Tax benefit for restricted stock vesting	188
Redemption of preferred stock		(13,000)
Sale of treasury stock	424	387
Net Cash (Used in) Provided by Financing Activities	(12,902)	20,582
Net Change in Cash and Cash Equivalents	984	8,615
Cash and Cash Equivalents at Beginning of Period	21,119	12,504
Cash and Cash Equivalents at End of Period	22,103	21,119
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for: Interest	3,264	2,718
Cash paid during the period for: Income taxes	1,175	1,777
Supplemental Disclosure of Non-cash Flow Information:
Transfers from loans to real estate owned and other repossessed property	26	$ 1,789
Non-cash assets acquired: Investment securities	3,027
Non-cash assets acquired: Loans	306,396
Non-cash assets acquired: Goodwill	15,590
Non-cash assets acquired: Core deposit intangible	508
Non-cash assets acquired: Other assests	10,838
Total non-cash assets acquired	336,359
Non-cash liabilities assumed: Deposits	227,153
Non-cash liabilities assumed: FHLBP advances	68,436
Non-cash liabilities assumed: Other liabilities	576
Total non-cash liabilities assumed	$ 296,165